Cas no 351457-84-6 (5-Bromo-4-methyl-3,3'-bipyridine)
5-Bromo-4-methyl-3,3'-bipyridine Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromo-4-methyl-3,3'-bipyridine
- 5-Bromo-4-methyl-3,3-bipyridine
- 3-bromo-4-methyl-5-pyridin-3-ylpyridine
- Z0535
-
- MDL: MFCD22543665
- Inchi: 1S/C11H9BrN2/c1-8-10(6-14-7-11(8)12)9-3-2-4-13-5-9/h2-7H,1H3
- InChI Key: DZHBJAONDAETMU-UHFFFAOYSA-N
- SMILES: BrC1=CN=CC(C2C=NC=CC=2)=C1C
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 14
- Rotatable Bond Count: 1
- Complexity: 186
- XLogP3: 2.5
- Topological Polar Surface Area: 25.8
5-Bromo-4-methyl-3,3'-bipyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB559167-250 mg |
5-Bromo-4-methyl-3,3'-bipyridine; . |
351457-84-6 | 250MG |
€317.90 | 2022-07-28 | ||
| abcr | AB559167-500 mg |
5-Bromo-4-methyl-3,3'-bipyridine; . |
351457-84-6 | 500MG |
€529.50 | 2022-07-28 | ||
| abcr | AB559167-1 g |
5-Bromo-4-methyl-3,3'-bipyridine; . |
351457-84-6 | 1g |
€721.90 | 2022-07-28 | ||
| Enamine | EN300-382112-0.05g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 0.05g |
$1428.0 | 2023-05-30 | ||
| Enamine | EN300-382112-0.1g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 0.1g |
$1496.0 | 2023-05-30 | ||
| Enamine | EN300-382112-0.25g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 0.25g |
$1564.0 | 2023-05-30 | ||
| Enamine | EN300-382112-0.5g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 0.5g |
$1632.0 | 2023-05-30 | ||
| Enamine | EN300-382112-1.0g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 1g |
$1701.0 | 2023-05-30 | ||
| Enamine | EN300-382112-2.5g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 2.5g |
$3332.0 | 2023-05-30 | ||
| Enamine | EN300-382112-5.0g |
3-bromo-4-methyl-5-(pyridin-3-yl)pyridine |
351457-84-6 | 5g |
$4930.0 | 2023-05-30 |
5-Bromo-4-methyl-3,3'-bipyridine Related Literature
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
Additional information on 5-Bromo-4-methyl-3,3'-bipyridine
Introduction to 5-Bromo-4-methyl-3,3'-bipyridine (CAS No. 351457-84-6)
5-Bromo-4-methyl-3,3'-bipyridine, with the chemical formula C10H10N2Bri, is a significant compound in the field of chemical and pharmaceutical research. This bipyridine derivative has garnered considerable attention due to its versatile applications in coordination chemistry, catalysis, and medicinal chemistry. The presence of both bromine and methyl substituents on the bipyridine core enhances its reactivity and utility in various synthetic transformations.
The compound's molecular structure, featuring a central bipyridine unit with bromine at the 5-position and a methyl group at the 4-position, makes it an attractive building block for designing complex molecular architectures. Its ability to act as a ligand in coordination chemistry has been exploited in the development of novel catalysts for organic transformations. For instance, transition metal complexes derived from 5-Bromo-4-methyl-3,3'-bipyridine have shown promise in cross-coupling reactions, which are pivotal in the synthesis of fine chemicals and pharmaceuticals.
In recent years, there has been a surge in research focusing on the applications of bipyridine derivatives in medicinal chemistry. The brominated and methylated versions of bipyridines have been particularly studied for their potential as pharmacophores. Notably, derivatives of this compound have been investigated for their roles in modulating enzyme activity and interacting with biological targets. Preliminary studies suggest that certain analogs may exhibit properties relevant to therapeutic applications, particularly in areas such as antiviral and anticancer research.
The synthesis of 5-Bromo-4-methyl-3,3'-bipyridine typically involves multi-step organic reactions, starting from readily available precursors. The bromination step is critical and often requires careful control of reaction conditions to ensure high selectivity. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions, have been employed to introduce the desired substituents efficiently. These synthetic approaches not only highlight the compound's synthetic utility but also contribute to the broader toolkit available for constructing complex organic molecules.
The compound's stability under various reaction conditions has made it a preferred choice for industrial applications as well. For example, it serves as an intermediate in the production of agrochemicals and specialty chemicals. Its role in these applications underscores its importance beyond academic research and into practical industrial processes. The ability to functionalize the bipyridine core with different substituents allows for tailoring its properties to meet specific industrial demands.
Recent advancements in computational chemistry have further enhanced our understanding of the reactivity and properties of 5-Bromo-4-methyl-3,3'-bipyridine. Molecular modeling studies have provided insights into how different substituents influence its coordination behavior and electronic properties. These computational insights are complemented by experimental data from spectroscopic techniques such as NMR and X-ray crystallography, which have been instrumental in elucidating its structure and bonding interactions.
The pharmaceutical industry has taken note of the potential of bipyridine derivatives like 5-Bromo-4-methyl-3,3'-bipyridine. Researchers are exploring its derivatives as candidates for drug development due to their unique structural features. The bromine atom provides a handle for further functionalization via Suzuki-Miyaura coupling reactions, allowing for the introduction of diverse pharmacophoric groups. This flexibility makes it an invaluable scaffold for medicinal chemists seeking to develop novel therapeutic agents.
The environmental impact of synthesizing and using 5-Bromo-4-methyl-3,3'-bipyridine is also a consideration that has gained traction in recent years. Efforts are being made to develop greener synthetic routes that minimize waste and reduce energy consumption. Catalytic methods that employ recyclable catalysts or operate under mild conditions are being explored as alternatives to traditional synthetic approaches. Such innovations not only improve sustainability but also enhance cost-effectiveness.
In conclusion, 5-Bromo-4-methyl-3,3'-bipyridine (CAS No. 351457-84-6) is a multifaceted compound with significant applications across multiple domains of chemistry and pharmaceutical science. Its unique structural features make it a valuable intermediate in coordination chemistry, catalysis, and drug discovery. As research continues to uncover new aspects of its reactivity and utility, this compound is poised to remain at the forefront of chemical innovation.
351457-84-6 (5-Bromo-4-methyl-3,3'-bipyridine) Related Products
- 15862-22-3(5-Bromo-3,3'-bipyridine)
- 88345-87-3(Pyridine, 3-bromo-4-(2-methylphenyl)-)
- 675590-28-0(3-Bromo-5-(p-tolyl)pyridine)
- 1359945-05-3(3-(4-Bromo-2-methylphenyl)pyridine)
- 675590-12-2(3-Bromo-5-(o-tolyl)pyridine)
- 51727-83-4(3,3'-Bipyridine, 5,5'-dibromo-)
- 27063-98-5(3-Bromo-4,5-dimethylpyridine)
- 142137-17-5(3-Bromo-5-phenylpyridine)
- 106047-38-5(5-Bromo-3,4'-bipyridine)
- 1070882-67-5(3-Bromo-5-(m-tolyl)pyridine)